United States · FDA National Drug Code directory
DNA Pancreas Formula
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83027-0302_7d796e80-6515-4f77-9d0a-40306c4c6360
- Product NDC
- 83027-0302
- Form
- SPRAY
- Composition / generic term
- Lycopodium Clavatum, Pancreas Suis, DNA, Insulinum (Human), Phosphoricum Acidum, Radium Bromatum, Uranium Nitricum
- Labeler
- Nutritional Specialties, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20260402
- Source listing expiry
- 20271231
Source-listed ingredients
- LYCOPODIUM CLAVATUM SPORE — 6 [hp_X]/mL
- SUS SCROFA PANCREAS — 9 [hp_X]/mL
- HERRING SPERM DNA — 30 [hp_X]/mL
- INSULIN HUMAN — 12 [hp_X]/mL
- PHOSPHORIC ACID — 30 [hp_X]/mL
- RADIUM BROMIDE — 60 [hp_X]/mL
- URANYL NITRATE HEXAHYDRATE — 30 [hp_C]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 60 mL in 1 BOTTLE, SPRAY (83027-0302-1) · 83027-0302-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →